Importantly, we found that the cyclic peptide vaccine and the humanized anti-TM4SF5 antibody suppressed the formation and growth of lung metastases, which were established by intravenous injection of colon cancer cells in a mouse metastasis model. Here, TM4SF5 is linked to malignant colon neoplasm.